Phase III Study of Induction and Consolidation Chemotherapy With Venetoclax in Patients With Newly Diagnosed AML or MDS-EB-2

PHASE3RecruitingINTERVENTIONAL
Enrollment

650

Participants

Timeline

Start Date

September 13, 2022

Primary Completion Date

March 31, 2029

Study Completion Date

February 29, 2032

Conditions
Acute Myeloid Leukemia
Interventions
DRUG

Venetoclax

Venetoclax will be administered in Induction cycle 1, Induction cycle 2 and in the chemo consolidation therapy in addition to the standard chemotherapy

DRUG

Placebo

Placebo will be administered in Induction cycle 1, Induction cycle 2 and in the chemo consolidation therapy in addition to the standard chemotherapy

COMBINATION_PRODUCT

Standard chemotherapy

"Induction cycle 1: Patients will receive cytarabine 200 mg/m2 continuous IV (days 1-7) and daunorubicin 60 mg/m2 IV (days 1-3). Induction cycle 2: Patients ≤ 60 yrs will receive cytarabine 1000 mg/m2 BID (3h IV), days 1-4, and daunorubicin 60 mg/m2 IV (days 1-3). Patients \>60 yrs will receive cytarabine 1000 mg/m2 BID (3h IV), days 1-4 without daunorubicin.~Consolidation chemotherapy with intermediate doses of cytarabine. Patients ≤60 yrs will receive up to 3 cycles of IDAC (single dose 1500 mg/m2 every 12 hours, days 1-3). Patients who are \>60 yrs will receive up to 3 cycles of IDAC with single doses of 1000 mg/m2, every 12 hours, days 1-3. In patients \>60 yrs less than 3 cycles of IDAC or dose-reduced IDAC (500 mg/m2 per single dose) may be given based on an individual risk assessment."

OTHER

Allogeneic stem cell transplantation

Generally, patients will proceed to allogeneic HCT upon completion of remission induction chemotherapy. It is however allowed, as per investigator's discretion, for a patient to receive 'bridging' consolidation chemotherapy in exceptional cases of delay towards transplantation. At baseline, HLA-compatible donor search must be initiated as soon as possible, first among siblings and second in the world donor bank for unrelated donors or cord blood. In order to avoid inappropriate delay in cases where no suitable sibling is present, high-resolution HLA typing should be performed immediately after registration, enabling a more rapid matched-unrelated donor search. In case no sibling or unrelated donor can be identified, haploidentical allogeneic HCT is allowed. Conditioning and GVHD prophylaxis will take place according to institutional guidelines. Patients who undergo allogeneic HCT will not receive venetoclax during conditioning, engraftment or after hematologic recovery.

Trial Locations (90)

10117

RECRUITING

Charité Berlin - Campus Mitte, Berlin

12200

RECRUITING

Charité Berlin - Campus Benjamin Franklin, Berlin

20246

RECRUITING

Universitätsklinikum Hamburg-Eppendorf, Hamburg

30625

RECRUITING

Medizinische Hochschule Hannover, Hanover

38114

RECRUITING

Staedtisches Klinikum Braunschweig, Braunschweig

44892

RECRUITING

Knappschaftskrankenhaus Bochum-Langendreer, Bochum

53127

RECRUITING

Uniklinikum Bonn, Bonn

70176

RECRUITING

Diakonie Klinikum Stuttgart, Stuttgart

72076

RECRUITING

Uniklinikum Tübingen, Tübingen

76133

RECRUITING

Städtisches Klinikum Karlsruhe, Karlsruhe

89081

RECRUITING

University Hospital Ulm, Ulm

Unknown

NOT_YET_RECRUITING

Tirol Kliniken GmbH, Innsbruck

NOT_YET_RECRUITING

Kepler Universitaetsklinikum GmbH, Linz

NOT_YET_RECRUITING

Ordensklinikum Linz GmbH, Linz

NOT_YET_RECRUITING

Landeskrankenhaus (LKH) Rankweil, Interne E am Landeskrankenhaus Rankweil, Rankweil

NOT_YET_RECRUITING

Gemeinnuetzige Salzburger Landeskliniken Betriebsgesellschaft mbH, Salzburg

NOT_YET_RECRUITING

Hanusch Krankenhaus Der Wiener Gebietskrankenkasse, Vienna

NOT_YET_RECRUITING

Ziekenhuis Aan De Stroom, Antwerp

NOT_YET_RECRUITING

Az St-Jan Brugge-Oostende A.V., Bruges

NOT_YET_RECRUITING

Universitair Ziekenhuis Brussel, Brussels

NOT_YET_RECRUITING

Katholieke Universiteit te Leuven, Leuven

NOT_YET_RECRUITING

Algemeen Ziekenhuis Delta, Roeselare

NOT_YET_RECRUITING

CHU UCL NAMUR - Mont Godinne, Yvoir

NOT_YET_RECRUITING

North Estonia Medical Centre Foundation, Tallinn

NOT_YET_RECRUITING

Tartu University Hospital, Tartu

NOT_YET_RECRUITING

Helsinki University Central Hospital Meilahden Kolmiosairaala, Helsinki

NOT_YET_RECRUITING

Tampere University Hospital, Tampere

RECRUITING

Klinikum Aschaffenburg-Alzenau gGmbH, Aschaffenburg

NOT_YET_RECRUITING

HELIOS Klinikum Bad Saarow GmbH, Bad Saarow

RECRUITING

Charité Berlin - Campus Virchow Klinikum, Berlin

NOT_YET_RECRUITING

Vivantes am Urban, Berlin

NOT_YET_RECRUITING

Vivantes Neukölln, Berlin

WITHDRAWN

Vivantes Spandau, Berlin

RECRUITING

Gesundheit Nord gGmbH Klinikverbund Bremen, Bremen

NOT_YET_RECRUITING

Klinikum Darmstadt GmbH, Darmstadt

NOT_YET_RECRUITING

St. Johannes Hospital Dortmund, Dortmund

NOT_YET_RECRUITING

Marien Hospital Duesseldorf GmbH, Düsseldorf

NOT_YET_RECRUITING

Klinikum Frankfurt Hoechst GmbH, Frankfurt

RECRUITING

Justus-Liebig-Universitaet Giessen, Giessen

RECRUITING

Wilhelm-Anton-Hospital Goch, Goch

NOT_YET_RECRUITING

Universitätsmedizin Greifswald, Greifswald

NOT_YET_RECRUITING

Asklepios Klinik Altona, Hamburg

RECRUITING

Asklepios Klinik St Georg, Hamburg

NOT_YET_RECRUITING

KRH Klinikum Siloah, Hanover

NOT_YET_RECRUITING

SLK-Kliniken Heilbronn GmbH, Heilbronn

RECRUITING

Marien Hospital Herne, Herne

NOT_YET_RECRUITING

Universitaetsklinikum des Saarlandes AöR, Homburg

NOT_YET_RECRUITING

Wespfalz-Klinikum, Kaiserslautern

NOT_YET_RECRUITING

Staedtisches Klinikum Karlsruhe gGmbH, Karlsruhe

RECRUITING

Klinikum der Stadt Ludwigshafen am Rhein gGmbH, Ludwigshafen

NOT_YET_RECRUITING

UNIVERSITÄTSKLINIKUM Schleswig-Holstein, Lübeck

NOT_YET_RECRUITING

Otto Von Guericke Universitaet Magdeburg, Magdeburg

NOT_YET_RECRUITING

Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz KöR, Mainz

RECRUITING

Klinikum Hochsauerland GmbH, Meschede

NOT_YET_RECRUITING

Muhlenkreiskliniken AöR, Minden

NOT_YET_RECRUITING

Klinikum rechts der Isar der TU Muenchen AöR, München

NOT_YET_RECRUITING

Ortenauklinikum, Offenburg

RECRUITING

Klinikum Oldenburg AöR, Oldenburg

NOT_YET_RECRUITING

Universitaetsklinikum Regensburg AöR, Regensburg

NOT_YET_RECRUITING

Universitaetsklinikum, Rostock

NOT_YET_RECRUITING

Klinikum Traunstein, Traunstein

NOT_YET_RECRUITING

Barmherzige Brueder Trier gGmbH, Trier

NOT_YET_RECRUITING

Klinikum Mutterhaus der Borromaerinnen, Trier

RECRUITING

Schwarzwald-Baar Klinikum Villingen-Schwenningen GmbH, Villingen-Schwenningen

NOT_YET_RECRUITING

Helios Universitaetsklinikum Wuppertal, Wuppertal

NOT_YET_RECRUITING

Vilnius University Hospital Santaros Klinik, Vilnius

NOT_YET_RECRUITING

Jeroen Bosch ziekenhuis, 's-Hertogenbosch

NOT_YET_RECRUITING

Meander Medisch Centrum, Amersfoort

RECRUITING

Amsterdam UMC Stichting, Amsterdam

NOT_YET_RECRUITING

OLVG, Amsterdam

NOT_YET_RECRUITING

Rijnstate Ziekenhuis Stichting, Arnhem

NOT_YET_RECRUITING

Amphia Hospital, Breda

NOT_YET_RECRUITING

Reinier de Graaf Gasthuis, Delft

NOT_YET_RECRUITING

Albert Schweitzer Ziekenhuis, Dordrecht

NOT_YET_RECRUITING

Maxima Medisch Centrum, Eindhoven

NOT_YET_RECRUITING

Medisch Spectrum Twente, Enschede

NOT_YET_RECRUITING

UMCG, Groningen

NOT_YET_RECRUITING

Medisch Centrum Leeuwarden B.V., Leeuwarden

NOT_YET_RECRUITING

Leids Universitair Medisch Centrum (LUMC), Leiden

NOT_YET_RECRUITING

Maastricht University Medical Center+ (MUMC+), Maastricht

NOT_YET_RECRUITING

Sint Antonius Ziekenhuis Stichting, Nieuwegein

RECRUITING

Radboudumc, Nijmegen

NOT_YET_RECRUITING

Erasmus MC - Daniel, Rotterdam

NOT_YET_RECRUITING

Hagaziekenhuis, locatie Leyweg, The Hague

NOT_YET_RECRUITING

UMCU, Utrecht

NOT_YET_RECRUITING

Isala Klinieken Stichting, Zwolle

NOT_YET_RECRUITING

Haukeland University Hospital, Bergen

NOT_YET_RECRUITING

Stavanger Univ. Hosp.-Rogaland Hosp., Oslo

NOT_YET_RECRUITING

University Hospital of North Norway, Tromsø

NOT_YET_RECRUITING

St. Olavs Hospital, Trondheim

All Listed Sponsors
collaborator

Stichting Hemato-Oncologie voor Volwassenen Nederland

OTHER

lead

University of Ulm

OTHER